San Francisco, March 08, 2022 (GLOBE NEWSWIRE) -- The global diabetes devices market size is expected to reach USD 44.6 billion by 2028, registering a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors such as increasing incidence of diabetes, technological advancements, and innovative product launches. Increasing adoption of advanced diabetes management solutions in developing region, government policies, and rising medical tourism are some of the major factors contributing to the market growth. Furthermore, rising government initiatives to spread awareness about diabetes and increasing R&D expenditure of major players are the factors expected to boost the market growth.
Key Insights & Findings from the report:
- North America accounted for the largest share in 2019, in terms of revenue, owing to favorable reimbursement policies, presence of key players, and frequent product launches.
- By product, the insulin delivery devices segment accounted for the largest market share and is also expected to grow at the fastest rate.
- In the Blood Glucose Monitoring (BGM) segment, self-monitoring devices dominated the market owing to their low cost and high usage.
- In Self-monitoring of Blood Glucose (SMBG) devices, testing strips segment dominated the market while blood glucose meters are expected to grow at a significant pace owing to high adoption and technological advancements.
- In the Continuous Glucose Monitoring (CGM) devices segment, transmitters accounted for the largest share owing to high cost of devices and high usage.
- In insulin delivery devices, pens segment dominated the market since it is easy to carry, easy to use, and has low cost as compared to other delivery devices.
- By distribution channel, hospital pharmacy segment dominated the market owing to rise in sales of diabetes devices in these pharmacies.
- By end use, hospital segment accounted for the largest market share owing to improving healthcare infrastructure due to rising investment.
Get Free Sample of this Research Report, “Diabetes Devices Market Size, Share & Trends Analysis Report By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel, By End-use (Hospitals, Homecare), By Region, And Segment Forecasts, 2021 - 2028”, published by Grand View Research.
Diabetes Devices Market Growth & Trends
According to a study published on National Center for Biotechnology Information (NCBI), global health expenditure on diabetes is expected to reach USD 490 billion in 2030 from 376 billion in 2010. Obesity, sedentary lifestyle, and fast food culture are some of the factors expected to have significant impact on the market growth. According to Harvard T.H. Chan School of Public Health, U.S. has the highest rates of obesity and it is expected to increase up to 50% by 2030.
In addition, increasing number of new market players, who focus on patient convenience with the help of artificial intelligence technology, are also transforming the market. They are leveraging technological advancements to improve diabetes care solutions like CGM devices, non-invasive insulin delivery systems, and digital diabetes management platforms. For instance, in December 2017, Companion Medical Launched Inpen, its first smart insulin pen system in the U.S. It is the only FDA-approved device that can combine insulin injector pen with a smart app.
Diabetes Devices Market Segmentation
Grand View Research has segmented global diabetes devices market on the basis of type, distribution channel, end-use, and region:
Diabetes Devices Type Outlook (Revenue, USD Million, 2016 - 2028)
- BGM Devices
- Self-Monitoring Devices
- Blood Glucose Meters
- Testing Strips
- Lancets
- Continuous Glucose Monitoring Devices
- Sensors
- Transmitters
- Receiver
- Self-Monitoring Devices
- Insulin Delivery Devices
- Pumps
- Pens
- Syringes
- Jet Injectors
Diabetes Devices Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)
- Hospital pharmacies
- Retail Pharmacies
- Diabetes Clinics/Centers
- Online Pharmacies
- Others
Diabetes Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)
- Hospitals
- Homecare
- Diagnostic Centers
Diabetes Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Czech Republic
- Poland
- Switzerland
- Turkey
- Asia Pacific
- Japan
- China
- India
- Australia
- Vietnam
- Philippines
- Malaysia
- Indonesia
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Oman
List of Key Players of Diabetes Devices Market
- Medtronic plc
- Abbott Laboratories
- F.Hoffmann-La-Ltd.
- Bayer AG
- Lifescan, Inc.
- B Braun Melsungen AG
- Lifescan, Inc.
- Dexcom Inc.
- Insulet Corporation
- Ypsomed Holdings
- Companion Medical
- Sanofi
- Valeritas Holding Inc.
- Novo Nordisk
- Arkray, Inc.
Check out more related studies published by Grand View Research:
- Europe Diabetes Devices Market - The Europe diabetes devices market size is expected to reach 8.7 billion by 2026, according to a new report by Grand View research, Inc. registering a CAGR of 4.0% over the forecast period. The size of the market is justified by the contribution from developed European economies such as Germany, U.K., France, and Italy. The prevalence of diabetes is rising amongst all ages in the European countries, mainly due to the unhealthy lifestyle, obesity, overweight, and physical inactivity.
- Digital Diabetes Management Market - The global digital diabetes management market size is expected to reach USD 26.4 billion by 2026, according to a new report by Grand View research, Inc., registering a 19.4% CAGR over the forecast period. The market is propelled by increasing number of product launches, coupled with innovation in technologies such as predictive analytics, Artificial Intelligence (AI), and Internet of Things (IoT).
- Continuous Glucose Monitoring Device Market - The global continuous glucose monitoring device market size is expected to reach USD 10.36 billion by 2028, according to a new study by Grand View Research, Inc. It is expected to expand at a CAGR of 10.1% from 2021 to 2028. Growing cases of diabetes and introduction of novel and advanced diabetes care devices are the major factors driving the market growth.
Browse through Grand View Research’s Medical Devices Industry Research Reports.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Grand View Compass | Grand View Pipeline
Follow Us: LinkedIn | Twitter
